Spectrum Pharmaceuticals (SPPI) Lawsuit Re-Opens Lead Plaintiff Process: New Lead Plaintiff Needed After Disqualification
San Francisco, California--(Newsfile Corp. - August 26, 2025) - A New York federal court has re-opened the lead plaintiff process in the Spectrum Pharmaceuticals (SPPI) securities class action, offering a new opportunity for investors to represent the class. The action follows the court's decision on August 4, 2025, to disqualify the previously appointed lead plaintiff. The new deadline to apply is September 24, 2025. Hagens Berman urges Spectrum investors who suffered substantial losses to...
2025-08-26 6:45 PM EDT
Investors Sue SelectQuote (SLQT) After DOJ Intervenes in Kickback Lawsuit - Hagens Berman
San Francisco, California--(Newsfile Corp. - August 26, 2025) - A new securities class-action lawsuit has been filed against SelectQuote, Inc. (NYSE: SLQT) and its executives after the U.S. Department of Justice (DOJ) announced its intervention in a separate lawsuit against the company. This federal involvement triggered a sharp 19% decline in SelectQuote's stock price on May 1, 2025, leading to significant investor losses. The lawsuit, known as Pahlkotter v. SelectQuote, Inc. et al., is on...
2025-08-26 4:20 PM EDT
CNC Investor Update: Lawsuit Filed Against Centene (CNC) Over Enrollment - Hagens Berman
San Francisco, California--(Newsfile Corp. - August 26, 2025) - A securities class-action lawsuit has been filed against Centene Corporation (NYSE: CNC), a major provider of healthcare services. The lawsuit, captioned Lunstrum v. Centene Corporation, seeks to represent investors who purchased Centene securities between December 12, 2024, and June 30, 2025. The lawsuit alleges that the company and its top executives presented a misleadingly optimistic view of its financial health, particularly...
2025-08-26 4:19 PM EDT
SRPT Update: Hagens Berman Urges Sarepta Investors to Act Before August 25 Deadline
San Francisco, California--(Newsfile Corp. - August 23, 2025) - A securities class-action lawsuit is underway against Sarepta Therapeutics (NASDAQ: SRPT), triggered by a series of safety concerns and regulatory setbacks for its gene therapy, ELEVIDYS. The lawsuit alleges that Sarepta misled investors by presenting ELEVIDYS as a safe and effective treatment with a clear path to broader regulatory approval. The deadline for investors with losses to be considered by the court to serve as Lead...
2025-08-23 4:26 PM EDT
Replimune (REPL) Faces Securities Class Action Following Stock's Collapse Amid FDA's Rejection of Melanoma Drug - Hagens Berman
San Francisco, California--(Newsfile Corp. - August 21, 2025) - A new securities class action has been initiated against Replimune Group, Inc. (NASDAQ: REPL) and certain executives, arising out of the company's recent stock price collapse. The lawsuit, officially known as Jboor v. Replimune Group, Inc., et al., No. 1:25-cv-12085 (D. Mass.), is on behalf of investors who acquired Replimune securities between November 22, 2024, and July 21, 2025. The legal action follows a dramatic one-day...
2025-08-21 4:42 PM EDT
HIMS 4-DAY DEADLINE ALERT: Hims & Hers (HIMS) Drops Amid Reported Details of FTC Investigation, Adding To Investor Scrutiny In Pending Securities Class Action - Hagens Berman
San Francisco, California--(Newsfile Corp. - August 21, 2025) - Investors who lost money in Hims & Hers (NYSE: HIMS) are being urged to actively participate in a securities class action lawsuit. The lawsuit alleges that Hims made misleading statements about its GLP-1 weight-loss drug business and its partnership with Novo Nordisk, which was abruptly canceled. This comes after Hims stock plummeted by over 34% on June 23, 2025, when Novo Nordisk ended the collaboration, citing Hims' "deceptive...
2025-08-21 4:31 PM EDT
SOC Update: Lawsuit Alleges Sable Offshore Misled Investors on Oil Production - Hagens Berman
San Francisco, California--(Newsfile Corp. - August 21, 2025) - A class-action lawsuit is underway against Sable Offshore Corp. (NYSE: SOC), alleging the company and its executives misrepresented its oil production status to investors. The lawsuit, captioned Johnson v. Sable Offshore Corp., represents those who purchased or acquired the company's publicly traded securities between May 19, 2025, and June 3, 2025. It also includes investors who bought shares in the company's secondary public...
2025-08-21 3:35 PM EDT
LMT Investor Update: Securities Lawsuit Hits Lockheed Martin (LMT) Over Program Losses -- Hagens Berman
San Francisco, California--(Newsfile Corp. - August 21, 2025) - A securities class action lawsuit has been filed against Lockheed Martin Corporation (NYSE: LMT) on behalf of investors who purchased shares between January 23, 2024, and July 21, 2025. The lawsuit, captioned Khan v. Lockheed Martin Corporation, alleges that the company misled investors about the financial health and performance of its Aeronautics and Rotary and Mission Systems (RMS) business segments. Hagens Berman encourages...
2025-08-21 3:32 PM EDT
Spectrum Pharmaceuticals (SPPI) Securities Lawsuit: New Lead Plaintiff Deadline Announced
San Francisco, California--(Newsfile Corp. - August 19, 2025) - A federal court has reopened the lead plaintiff process in the Spectrum Pharmaceuticals (SPPI) securities class action, setting a new deadline of September 24, 2025. This comes after the previous lead plaintiff was disqualified in an order on August 4, 2025. Hagens Berman urges Spectrum investors who suffered substantial losses to submit your losses now. Class Period: Mar. 17, 2022 - Sept. 22, 2022 Lead Plaintiff Deadline: Sept....
2025-08-19 6:26 PM EDT
SRPT 6-DAY DEADLINE ALERT: Sarepta Therapeutics (SRPT) August 25, 2025 Lead Plaintiff Deadline Approaching, SRPT Investors with Substantial Losses Encouraged to Contact Hagens Berman
San Francisco, California--(Newsfile Corp. - August 19, 2025) - The pending securities class action was triggered after news of safety problems with Sarepta's (NASDAQ: SRPT) ELEVIDYS, a medication intended for the treatment of Duchenne muscular dystrophy. The deadline for Sarepta investors with losses who wish to be considered by the court to serve as Lead Plaintiff is August 25, 2025. Accordingly, national shareholders rights firm Hagens Berman urges Sarepta investors who suffered...
2025-08-19 6:22 PM EDT
SelectQuote (SLQT) Securities Lawsuit: What Investors Need to Know - Hagens Berman
San Francisco, California--(Newsfile Corp. - August 19, 2025) - A securities class action lawsuit has been filed against SelectQuote (NYSE: SLQT) after the U.S. Department of Justice (DOJ) announced it was intervening in a separate lawsuit against the company. The news of the DOJ's involvement caused a significant 19% drop in SelectQuote's stock price on May 1, 2025. The class action, known as Pahlkotter v. SelectQuote, Inc. et al., No. 1:25-cv-06620 (S.D.N.Y.), seeks to represent investors...
2025-08-19 5:49 PM EDT
Centene Corporation (CNC) Faces Shareholder Ire Amidst Plummeting Stock and Lawsuit Over "Inflated Guidance" - Hagens Berman
San Francisco, California--(Newsfile Corp. - August 19, 2025) - Before the markets opened on July 25, 2025, investors in Centene Corporation (NYSE: CNC) saw the price of their shares decline about 10% in pre-market trading after the company reported disastrous Q2 2025 financial results. The company, a prominent provider of government-sponsored and commercial healthcare services, finds itself embroiled in a class action lawsuit following a dramatic plunge in its stock price. The suit, Lunstrum...
2025-08-19 5:46 PM EDT
Nutex Health (NUTX) Delays Filing Quarterly Report, Shares Tank Again After Critical Blue Orca Report -- Hagens Berman
San Francisco, California--(Newsfile Corp. - August 19, 2025) - Shares of Nutex Health Inc. (NASDAQ: NUTX) experienced a precipitous decline today, falling as much as 24% in intraday trading. The significant drop followed the company's disclosure that it would not timely submit its financial results for the quarter ended June 30, 2025 - a development related to an ongoing investigation by law firm Hagens Berman into possible securities violations. The firm urges Nutex investors who suffered...
2025-08-19 12:42 PM EDT
Lockheed Martin (LMT) Faces Investor Scrutiny Over Company's Disclosures About Aeronautics and RMS Segments' Performance, Securities Class Action Pending -- Hagens Berman
San Francisco, California--(Newsfile Corp. - August 14, 2025) - A securities class action lawsuit styled Khan v. Lockheed Martin Corporation, et al., No. 1:25-cv-06197 (S.D.N.Y.) has been filed and seeks to represent investors who purchased or otherwise acquired Lockheed Martin Corporation (NYSE: LMT) securities between January 23, 2024 and July 21, 2025. The lawsuit comes in the wake of Lockheed's Q2 2025 financial results, which resulted in the price of the company shares falling almost 11%...
2025-08-14 4:11 PM EDT
Sable Offshore Corp. (SOC) Hit with Lawsuit Over Alleged Misleading Statements on California Oil Restart - Hagens Berman
San Francisco, California--(Newsfile Corp. - August 14, 2025) - Sable Offshore Corp. (NYSE: SOC) is now at the center of a securities class-action lawsuit, alleging that the company misled investors to inflate its stock price just before a major secondary offering. The drama unfolded around the company's long-delayed efforts to restart operations at its San Ynez Unit (SYU) assets, which have been dormant since a pipeline shutdown in 2015. National shareholders rights firm Hagens Berman urges...
2025-08-14 4:02 PM EDT
Replimune (REPL) Faces Securities Class Action Following Stock's Collapse Amid FDA's Rejection of Melanoma Drug - Hagens Berman
San Francisco, California--(Newsfile Corp. - August 14, 2025) - A securities class action lawsuit, styled Jboor v. Replimune Group, Inc., et al., No. 1:25-cv-12085 (D. Mass.), has been filed and seeks to represent investors who purchased or otherwise acquired Replimune (NADAQ: REPL) securities between November 22, 2024 and July 21, 2025. The lawsuit comes after Replimune investors witnessed a 77% collapse in the price of their shares on July 22 when the company announced that the Food and...
2025-08-14 3:55 PM EDT
HIMS CEO Family Trust Sells $33M Shares Following Novo Nordisk Accusations - Hagens Berman
San Francisco, California--(Newsfile Corp. - August 14, 2025) - On August 7, 2025, the Dudham Family Heritage Trust sold 660,000 shares of Hims & Hers Health (NYSE: HIMS) for total proceeds of over $33 million. The move is notable for its size and comes after two sharp declines amid pharmaceutical giant Novo Nordisk's decision to abruptly cancel its two-month-old collaboration with Hims to expand the availability of one of two FDA-approved weight loss drugs -- Wegovy® -- and Hims' subsequent...
2025-08-14 3:24 PM EDT
Centene Corporation (CNC) Shares Fall ~10% Pre-Market After Reporting Q2 2025 Diluted Loss Per Share, Class Action Lawsuit Over "Inflated Guidance" Pending - Hagens Berman
San Francisco, California--(Newsfile Corp. - August 12, 2025) - Before the markets opened on July 25, 2025, investors in Centene Corporation (NYSE: CNC) saw the price of their shares decline about 10% in pre-market trading after the company reported disastrous Q2 2025 financial results. The company, a prominent provider of government-sponsored and commercial healthcare services, finds itself embroiled in a class action lawsuit following a dramatic plunge in its stock price. The suit, Lunstrum...
2025-08-12 1:33 PM EDT
Sarepta Therapeutics (SRPT) Declines Again On EMA Recommendation to Refuse ELEVIDYS Marketing Authorization, Securities Class Action Pending - Hagens Berman
San Francisco, California--(Newsfile Corp. - August 12, 2025) - On July 24, 2025, the European Medicines Agency ("EMA") recommended the refusal of the marketing authorization for ELEVIDYS, Sarepta's medication intended for the treatment of Duchenne muscular dystrophy. This news prompted another significant decline in the price of Sarepta (NASDAQ: SRPT) shares. The EMA's recommendation follows a slew of bad news for Sarepta investors, including patient deaths that resulted in sharp stock price...
2025-08-12 1:25 PM EDT
Lockheed Martin (LMT) Faces Investor Scrutiny Over Company's Disclosures About Aeronautics and RMS Segments' Performance, Securities Class Action Pending -- Hagens Berman
San Francisco, California--(Newsfile Corp. - August 7, 2025) - A securities class action lawsuit styled Khan v. Lockheed Martin Corporation, et al., No. 1:25-cv-06197 (S.D.N.Y.) has been filed and seeks to represent investors who purchased or otherwise acquired Lockheed Martin Corporation (NYSE: LMT) securities between January 23, 2024 and July 21, 2025. The lawsuit comes in the wake of Lockheed's Q2 2025 financial results, which resulted in the price of the company shares falling almost 11%...
2025-08-07 9:59 AM EDT